Surveillance of Transmitted Drug-Resistant HIV Among Young Pregnant Women in Ouagadougou, Burkina Faso
Authors:
- 27 April 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 54 (suppl 4) , S317-S319
Abstract
Burkina Faso began rapid antiretroviral therapy (ART) scale-up in 2003 and by December 2009, 26,448 individuals were on treatment. With rapid scale-up of ART, some degree of human immunodeficiency virus transmitted drug resistance (TDR) is inevitable. Following World Health Organization methods, between June 2008 and July 2009, Burkina Faso assessed TDR in primigravid pregnant women aged <25 years attending antenatal care clinics in Ouagadougou, Burkina Faso. TDR was classified as moderate (5%-15%) for both nucleoside reverse-transcriptase inhibitors and nonnucleoside reverse-transcriptase inhibitors. The observed moderate TDR in Ouagadougou is a cause for concern and calls for closer monitoring of Burkina Faso's ART program.Keywords
This publication has 18 references indexed in Scilit:
- Low Prevalence of HIV Type 1 Drug Resistance Mutations in Untreated, Recently Infected Patients from Burkina Faso, Côte d'Ivoire, Senegal, Thailand, and Vietnam: The ANRS 12134 StudyAIDS Research and Human Retroviruses, 2009
- The calibrated population resistance tool: standardized genotypic estimation of transmitted HIV-1 drug resistanceBioinformatics, 2009
- World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sitesAntiviral Therapy, 2008
- Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatmentAntiviral Therapy, 2008
- Surveillance of transmitted HIV drug resistance among women attending antenatal clinics in Dar es Salaam, TanzaniaAntiviral Therapy, 2008
- The World Health Organization's global strategy for prevention and assessment of HIV drug resistanceAntiviral Therapy, 2008
- Surveillance of transmitted HIV drug resistance with the World Health Organization threshold survey method in Lilongwe, MalawiAntiviral Therapy, 2007
- HIV-1 Drug-Resistance Mutations among Newly Diagnosed Patients before Scaling-Up Programmes in Burkina Faso and CameroonAntiviral Therapy, 2006
- Clinical Use of Genotypic and Phenotypic Drug Resistance Testing to Monitor Antiretroviral ChemotherapyClinical Infectious Diseases, 2001
- The Relation between Baseline HIV Drug Resistance and Response to Antiretroviral Therapy: Re-Analysis of Retrospective and Prospective Studies Using a Standardized Data Analysis PlanAntiviral Therapy, 2000